Cercar
01/09/2024
Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period
Somolinos-Simón, FJ, García-Sáez, G, Tapia-Galisteo, J, Corcoy, R, Hernando, ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 215DOI:10.1016/j.diabres.2024.111803. PMID:39089589. IF:7.400(Q1/1D).
01/09/2024
Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy
Cheng, A, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, M, Bonnemaire, M, Lydie, MM, Mimouni, S, Davies, M. Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation
Claramunt, FC, Lazaro, D, Salter, J, Paldánius, P, Mauricio, D. Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study
Torre, ELM, Alarcón, PP, Rodríguez, MM, Serrallonga, NB, Palomar, JR, Iglesias, DM, Hoyas, CN, Servat, OS, Kyriakos, G, Bellas, LC, Pla, RC, Ramonde, TM, López, ML, Madorell, BS, Borrás, JG. Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects
Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/08/2024
Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study
Vlacho, B, Iniesta, AM, Gratacòs, M, Mata-Cases, M, Rubinat, E, Berenguera, A, Cos, FX, Franch-Nadal, J, Mauricio, D. Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study. Primary Care Diabetes. 2024; 18(4)DOI:10.1016/j.pcd.2024.05.001. PMID:38782704. IF:2.300(Q2/5D).
01/08/2024
DECIPHERING THE EXTRACELLULAR EFFECTS OF SUCCINATE IN ATHEROSCLEROTIC DISEASE PROGRESSION: A TRANSLATIONAL APPROACH
Giné, LC, Caro-Pérez, P, Villanueva-Carmona, T, Rodríguez-Peña, MM, Núñez-Roa, C, Granado-Casas, M, Santos, D, Mauricio, D, Rotllan, N, Escola-Gil, JC, Vendrell, J, Fernández-Veledo, S. DECIPHERING THE EXTRACELLULAR EFFECTS OF SUCCINATE IN ATHEROSCLEROTIC DISEASE PROGRESSION: A TRANSLATIONAL APPROACH. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
Orna, JAG, Martínez, ABM, Padial, LR, Sánchez, MA, Barrios, V, García, JM, Perez, AP. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial. Endocrinologia Diabetes y Nutricion. 2024; 71(7)DOI:10.1016/j.endien.2024.07.001. PMID:39095283. IF:1.800(Q3/8D).